SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-19-009773
Filing Date
2019-05-30
Accepted
2019-05-30 09:46:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d0519platt_bioxytran.htm SC 13D 49536
  Complete submission text file 0001213900-19-009773.txt   51117
Mailing Address 12 APPLETON CIRCLE NEWTON MA 02459
Business Address
PLATT DAVID (Filed by) CIK: 0001166440 (see all company filings)

Type: SC 13D

Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Subject) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-84839 | Film No.: 19864884
SIC: 2834 Pharmaceutical Preparations